Literature DB >> 15892149

Sequence variants of the DRD4 gene in autism: further evidence that rare DRD4 7R haplotypes are ADHD specific.

D L Grady1, A Harxhi, M Smith, P Flodman, M A Spence, J M Swanson, R K Moyzis.   

Abstract

A high prevalence of rare dopamine receptor D4 (DRD4) alleles in children diagnosed with attention-deficit hyperactivity disorder (ADHD) has been reported [Grady et al., 2003]. In this prior study, extensive resequencing/haplotype data of the DRD4 locus was used to suggest that population stratification was not the explanation for the high prevalence of rare alleles. In the current study, DNA resequencing/haplotyping was conducted on 136 DRD4 alleles obtained from autism probands, collected from the same geographic population as the prior ADHD probands (Orange County, CA). A number of studies have suggested that the susceptibility genes underlying these two disorders might partially overlap. Rare DRD4 variants were not uncovered in this autism sample beyond that expected by chance. These results suggest strongly that the high prevalence of rare DRD4 alleles in ADHD probands is due to ascertainment of the sample by diagnosis of ADHD. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892149     DOI: 10.1002/ajmg.b.30182

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  14 in total

1.  Association between DRD4 genotype and Autistic Symptoms in DSM-IV ADHD.

Authors:  Angela M Reiersen; Alexandre A Todorov
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-02

2.  SLC9A9 mutations, gene expression, and protein-protein interactions in rat models of attention-deficit/hyperactivity disorder.

Authors:  Yanli Zhang-James; Tania DasBanerjee; Terje Sagvolden; Frank A Middleton; Stephen V Faraone
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-19       Impact factor: 3.568

Review 3.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

4.  Klerman's "credo" reconsidered: neo-Kraepelinianism, Spitzer's views, and what we can learn from the past.

Authors:  Jerome C Wakefield
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

5.  Increased brain activity to unpleasant stimuli in individuals with the 7R allele of the DRD4 gene.

Authors:  Jean-G Gehricke; James M Swanson; Sophie Duong; Jenny Nguyen; Timothy L Wigal; James Fallon; Cyrus Caburian; Lutfi Tugan Muftuler; Robert K Moyzis
Journal:  Psychiatry Res       Date:  2014-11-04       Impact factor: 3.222

Review 6.  Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder.

Authors:  Nanda N J Rommelse; Barbara Franke; Hilde M Geurts; Catharina A Hartman; Jan K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-11       Impact factor: 4.785

7.  DRD4 genotype predicts longevity in mouse and human.

Authors:  Deborah L Grady; Panayotis K Thanos; Maria M Corrada; Jeffrey C Barnett; Valentina Ciobanu; Diana Shustarovich; Anthony Napoli; Alexandra G Moyzis; David Grandy; Marcelo Rubinstein; Gene-Jack Wang; Claudia H Kawas; Chuansheng Chen; Qi Dong; Eric Wang; Nora D Volkow; Robert K Moyzis
Journal:  J Neurosci       Date:  2013-01-02       Impact factor: 6.167

8.  The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence.

Authors:  Andrew W Bergen; Harold S Javitz; Li Su; Yungang He; David V Conti; Neal L Benowitz; Rachel F Tyndale; Caryn Lerman; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2012-12-03       Impact factor: 4.244

Review 9.  Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders.

Authors:  Radek Ptácek; Hana Kuzelová; George B Stefano
Journal:  Med Sci Monit       Date:  2011-09

10.  DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.

Authors:  Darko Turic; James Swanson; Edmund Sonuga-Barke
Journal:  Pharmgenomics Pers Med       Date:  2010-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.